| Literature DB >> 28973488 |
Peiqin Xue1, Xiaojun Zhao1, Mengbei Qin1, Zhanghuan Shi1, Min Zhang1, Wei Gu1.
Abstract
Ethylparaben (EP) has been shown to have estrogenic effects and can affect the normal development, longevity, and reproductive system of some animals. In this study, we investigated the effects of EP in male Drosophila melanogaster using transcriptome analysis or digital gene expression profiling. We then screened differentially expressed genes (DEGs) between the two groups (EP-treated and control group) of Drosophila, and performed clustering analysis, gene ontology (GO) function annotation, kyoto encyclopedia of gene and genomes metabolic pathway analysis. We found that EP enriched GO in three processes: cellular component, molecular function, and biological process. Consequently, we detected 13,959 genes and among them, 18 genes were identified to be significantly expressed between the EP-treated and control samples. Of these, seven genes were down-regulated, and eleven genes were up-regulated in EP-treated samples. Furthermore, four DEGs including two down-regulated genes (CG9465, CG9468) and two up-regulated genes (TotA, Sqz) were verified by real-time quantitative PCR. This study revealed the impact of EP on gene expression in fruit fly and provided new insight into the mechanisms of this response, which is helpful for understanding EP toxicity to humans.Entities:
Keywords: Drosophila melanogaster; differentially expressed gene; digital gene expression profiling; ethylparaben; response mechanism
Mesh:
Substances:
Year: 2017 PMID: 28973488 PMCID: PMC5510984 DOI: 10.1093/jisesa/iex050
Source DB: PubMed Journal: J Insect Sci ISSN: 1536-2442 Impact factor: 1.857
Basic characteristics of tags in four libraries and sequencing reads mapping to the reference genome
| Sample name | Ctl-DM1 | Ctl-DM2 | EP-DM1 | EP-DM2 |
|---|---|---|---|---|
| Total clean reads | 13,236,139 | 9,351,457 | 8,059,462 | 6,456,485 |
| Total mapped | 12,377,599 (93.51%) | 8,754,283 (93.61%) | 7,509,746 (93.18%) | 6,032,355 (93.43%) |
| Multiple mapped | 340,401 (2.57%) | 239,204 (2.56%) | 185,608 (2.3%) | 156,740 (2.43%) |
| Uniquely mapped | 12,037,198 (90.94%) | 8,515,079 (91.06%) | 7,324,138 (90.88%) | 5,875,615 (91%) |
| Reads map to “+” | 6,033,489 (45.58%) | 4,263,653 (45.59%) | 3,671,979 (45.56%) | 2,942,992 (45.58%) |
| Reads map to “-” | 6,003,709 (45.36%) | 4,251,426 (45.46%) | 3,652,159 (45.32%) | 2,932,623 (45.42%) |
| Nonsplice reads | 11,086,504 (83.76%) | 7,828,127 (83.71%) | 6,730,954 (83.52%) | 5,396,636 (83.58%) |
| Splice reads | 950,694 (7.18%) | 686,952 (7.35%) | 593,184 (7.36%) | 478,979 (7.42%) |
Refers to sense strands.
Refers to anti-sense strands.
Refer to reads for the entire sequence is mapped to one exon.
Splice reads also called junction reads, refers to reads mapped to the border of exon.
List of all the different genes between control and ethylparaben group and pathways in which the different genes related to EP exposure are active
| Gene ID | Gene name | Readcount EP_DM | Readcount DM | Log 2 fold change | Padj | Pval | Regulated | Gene annotation |
|---|---|---|---|---|---|---|---|---|
| FBgn0010768 | 114.41 | 49.19 | 1.22 | 0.03 | 3.35E-05 | Up | Metal ion binding, nucleic acid binding, sequence-specific DNA binding, transcription factor activity. | |
| FBgn0028396 | 1,194.98 | 684.24 | 0.80 | 0.01 | 6.33E-06 | Up | Elemental activities, such as catalysis or binding, describing the actions of a gene product at the molecular level.A given gene product may exhibit one or more molecular functions. | |
| FBgn0032067 | 9.56 | 83.35 | −3.12 | 0.01 | 9.71E-07 | Down | Alpha-mannosidase activity, carbohydrate binding, zinc ion binding. | |
| FBgn0032068 | 914.92 | 2,017.87 | −1.14 | 0.01 | 2.04E-07 | Down | Alpha-mannosidase activity, carbohydrate binding, zinc ion binding. | |
| FBgn0032069 | 1,675.59 | 4,500.58 | −1.43 | 2.01E-13 | 1.44E-17 | Down | Alpha-mannosidase activity, carbohydrate binding, zinc ion binding. | |
| FBgn0032144 | 1,471.66 | 862.90 | 0.77 | 0.01 | 1.10E-05 | Up | Metallocarboxypeptidase activity, zinc ion binding. | |
| FBgn0032147 | 473.77 | 266.86 | 0.83 | 0.04 | 5.81E-05 | Up | NOT calmodulin binding, inositol-1,4,5-trisphosphate 3-kinase activity. | |
| FBgn0033294 | 273.04 | 1,097.74 | −2.01 | 0.01 | 8.20E-06 | Down | Alpha-glucosidase activity, cation binding. | |
| FBgn0033592 | 63.08 | 16.19 | 1.96 | 0.01 | 1.16E-06 | Up | Protein coding. | |
| FBgn0035154 | 409.60 | 218.41 | 0.91 | 0.01 | 4.05E-06 | Up | Serine-type carboxypeptidase activity. | |
| FBgn0035358 | 534.88 | 275.30 | 0.96 | 0.04 | 5.53E-05 | Up | Protein coding. | |
| FBgn0036619 | 330.99 | 102.26 | 1.69 | 2.94E-05 | 6.33E-09 | Up | Structural constituent of chitin-based cuticle. | |
| FBgn0036764 | 314.55 | 163.56 | 0.94 | 0.02 | 2.01E-05 | Up | Amino acid transmembrane transporter activity, cationic amino acid transmembrane transporter activity. | |
| FBgn0037782 | 6.80 | 88.36 | −3.70 | 1.73E-11 | 2.48E-15 | Down | Sterol binding. | |
| FBgn0051233 | 2,936.77 | 1,808.36 | 0.70 | 0.03 | 2.74E-05 | Up | Aminopeptidase activity, metallopeptidase activity, zinc ion binding. | |
| FBgn0051664 | 35.15 | 102.70 | −1.55 | 0.01 | 1.15E-05 | Down | Protein coding. | |
| FBgn0085232 | 76.97 | 27.15 | 1.50 | 0.02 | 2.27E-05 | Up | Protein coding. | |
| FBgn0263336 | 257.68 | 597.55 | −1.21 | 0.01 | 1.17E-06 | Down | ncRNA, putative noncoding RNA. |
Fig. 1.GO functional enrichment of genes differentially expressed between the control and EP-treated group in biological process (a), cellular component (b), molecular function (c). Gene classification based on gene ontology (GO) for differentially expressed genes in the two groups. The number of genes in GO terms was analyzed using GO Slim Assignment.
Fig. 2.GO analysis of differentially expressed genes between the control and EP-treated group. The differentially expressed genes are classified into three categories, cellular component, molecular function, and biological process. The flowing axis shows number of genes, with ‘*’ for the enrichment of GO term.
The primers used in qRT-PCR
| Gene | Primer sequence |
|---|---|
| 5′-ATGACCATCCGCCCAGCATAC-3′ | |
| 5′-GCATCAGATACTGTCCCTTGAAGC-3′ | |
| 5′-TCAATAGCACCCAG GAACTAC-3′ | |
| 5′-AGAATCCAGTTGCAAGGC-3′ | |
| 5′-CGAGC AGCAGGAACAGAAGT-3′ | |
| 5′-TCGCAAAACAATCCGAAGCA-3′ | |
| 5′-TCGCAAAACAATCCGAAGCA-3′ | |
| | 5′-TTGTTTC GGGACATGACTGC-3′ |
| | 5′-ATTTGTGCGGCATTGTGCTT-3′ |
| | 5′-TCCTGTCGCATTCTGGCATT-3′ |
Fig. 3.qRT-PCR validations of expression levels of candidate genes from DGE analysis. Quantitative RT-PCR validation of differentially expressed genes in control (a basal diet) and treatment (diet with 700 mg/liter EP) samples. Up-regulated genes (a): ToA; (b): Sqz; down-regulated genes; (c): CG9465; (d): CG9468). All data were normalized to the expression level of actin. Data represent fold change of relative quantification in treatment and control groups. The error bars represent the range of the fold change as determined by the data assist software.